Steven O'Day
3PUBLICATIONS
60CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Jul 31, 2024
Botensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy.Dhan Chand, David A Savitsky, Shanmugarajan Krishnan
|Dec 20, 2023
Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study.Pamela Munster, Nicholas Iannotti, Daniel C Cho
|Jun 28, 2023
Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial.Espen B Ellingsen, Steven O'Day, Artur Mezheyeuski
Pageof 1
Frequent Collaborators
1 joint publications
Dhan Chand
1 joint publications
David A Savitsky
1 joint publications
Shanmugarajan Krishnan
1 joint publications
Gabriel Mednick
1 joint publications
Chloe Delepine
1 joint publications
Pilar Garcia-Broncano
1 joint publications
Kah Teong Soh
1 joint publications
Wei Wu
1 joint publications
Margaret K Wilkens
1 joint publications
Olga Udartseva
